In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test

Mycoses

Volumn 42, Issue 11-12, 1999, Pages 629-639

  Nenoff, P ^a,b   Oswald, Ulrike ^a   Haustein, U F ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Candida albicans; Fluconazole; Itraconazole; Susceptibility testing; Yeasts

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DRUG SENSITIVITY; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL;

ANTIFUNGAL AGENTS; CANDIDA; CRYPTOCOCCUS; FLUCONAZOLE; GEOTRICHUM; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; SACCHAROMYCES; TRICHOSPORON; YEASTS;

EID: 0033369529     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0507.1999.00510.x     Document Type: Article

References (34)

1. 1 Warnock, D. W. & Johnson, E. M. (1997) Azole drug resistance as a cause of treatment failure in patients with candidosis. In: Jacobs, P. H. & Nall, L. (eds) Fungal Disease. Biology, Immunology and Diagnosis. New York Basel Hong Kong: Marcel Dekker, Inc., pp. 487-499.
2. 2 Ng, T. T. C. & Denning, D. W. (1993) Fluconazole resistance in Candida in patients with AIDS a therapeutic approach. J. Infect. 26, 117-125.
3. 3 Odds, F. C. (1993) Resistance of yeasts to azole-derivative antifungals. J. Antimcrob. Chemother. 31, 463-471.
4. 4 Rex, J. H., Rinaldi, M. G. & Pfaller, M. A. (1995) Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39, 1-8.
5. 5 Schmalreck, A.-F. & Fegeler, W. (1996) Kriterien zur Empfindlichkeitsprüfung von Fluconazol im Mikrodilutionstest: Vorschlag für eine standardisierte Methode zur Testung von Sproßpilzen. Mycoses 39 (Suppl. 2), 12-16.
6. 6 National Committee for Clinical Laboratory Standards. (1997) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved standard. M27-A. Vol. 17, No. 9, June 1997. Wayne, Pennsylvania: Natl. Committee for Clin. Laboratory Standards.
7. 5,6-desaturation. FEBS Lett 400, 80-82.
8. 8 Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.-L., Monod, M. & Bille, J. (1995) Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve multidrug transporters. Antimicrob. Agents Chemother. 39, 2378-2386.
9. 9 Richardson, M. D. & Warnock, D. W. (1997) Fungal infection. Diagnosis and Management. 2nd edn., Berlin, Tokyo: Blackwell Science.
10. 10 Pfaller, M. A. & Rinaldi, M. G. (1993) Antifungal susceptibility testing. Current state of technology, limitations, and standardization. Inf. Dis. Clin. North Am. 7, 435-444.
11. 11 Schmalreck, A. F., Kottmann, I., Reiser, A., Ruffer, U., Scharr, E. & Vanca, E. (1995) An evaluation of seven methods of testing in vitro susceptibility of clinical yeast isolates to fluconazole. Mycoses 38, 359-368.
12. 12 Anon: (1997) Medical microbiology-Susceptibility testing of fungi against antifungal agents. Part. 84: Microdilution - Method-specific requirements. Proposal. Normenausschuß Medizin (Named) DIN Deutsches Institut für Normung E. V., Ref. Nr. E DIN 58940-84, Berlin, Germany: Deutsches Institut für Normung E. V.
13. 13 Pfaller, M. A., Grant, C., Morthland, V. & Rhine-Chalberg, J. (1994) Comparative evaluation of alternative methods for broth dilution susceptibility testing of fluconazole against Candida albicans. J. Clin. Microbiol. 32, 506-509.
14. 14 Ruhnke, M., Schmidt-Westhausen, A., Engelmann, E. & Trautmann, M. (1994) Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy. J. Clin. Microbiol. 34, 3208-3211.
15. 15 Ruhnke, M., Eigler, A., Tennagen, I., Geiseler, B., Engelmann, E. & Trautmann, M. (1994) Emergence of fluconazole-resislant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32, 2092-2098.
16. 16 Ruhnke, M., Schmidt-Westhausen, A. & Trautmann, M. (1996) Vergleich von drei Antimykotika-Empfindlichkeitsprüfungs-Methoden für die In-vitro-Testung von Candida-Isolaten von Patienten mit HIV-Infektion. Mycoses 39 (Suppl. 2), 47-50.
17. 17 Nenoff, P., Taneva, E., Oswald, U., Pfeil, B. & Haustein, U.-F. (1999) In. vitro activity of rilopirox, a novel hydroxypyridone antifungal, against fluconazole-susceptible and-resistant Candida isolates from patients with human immunodeficiency virus infection. Mycoses 42, 55-60.
18. 18 Wildfeuer, A. & Seidl, H. P. (1994) The in vitro activity of fluconazole against fungi involved in dermal infections. Mycoses 37, 447-449.
19. 19 Ramani, R., Ramani, A. & Wong, S. J. (1997) Rapid flow cytometric susceptibility testing of Candida albicans. J. Clin. Microbiol. 35, 2320-2324.
20. 20 Hundt, W. & Hofmann, H. (1994) In vitro susceptibility and sterol biosynthesis of Candida albicans strains after long term treatment with azoles in HIV-infected patients. Infection 22, 64-71.
21. 21 Morace, G., Manzara, S. & Dettori, G. (1991) In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole. Chemotherapy 37, 23-31.
22. 22 Hoppe, J. E., Klingebiel, T. & Niethammer, D. (1994) Selection of Candida glabrata in pediatric bone marrow transplant recipients receiving fluconazole. Pediatr. Hematol. Oncol. 11, 207-210.
23. 23 Rex, J. H., Pfaller, M. A., Galgiani, J. N., et al. (1997) Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro - in vivo correlation data for fluconazole, itraconazole, and Candida infection. Clin. Inf. Dis. 24, 235-247.
24. 24 Warnock, D. W., Burke, J., Cope, N. J., Johnson, E. M., von Fraunhofer, N. A. & Williams, E. W. (1988) Fluconazole resistance in Candida glabrata. Lancet ii, 1310.
25. 25 Hitchcock, C. A., Pye, G. W., Troke, P. F., Johnson, E. M. & Warnock, D. W. (1993) Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37, 1962-1965.
26. 26 Vanden Bossche, H., Marichal, P., Odds, F. C., Le Jeune, L. & Coene, M.-C. (1992) Characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 36, 2602-2610.
27. 27 Tiballi, R. N., Zarins, L. T., He, X. & Kauffman, C. A. (1995) Torulopsis glabrata: azole susceptibility by microdilution colorimetric and macrodilution broth assays. J. Clin. Microbiol. 33, 2612-2615.
28. 28 Lewis, R. E., Lund, B. C., Klepser, M. E., Ernst, E. J. & Pfaller, M. A. (1998) Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model. Antimicrob. Agents Chemother. 42, 1382-1386.
29. 29 Tintelnot, K. & Seibold, M. (1996) Kontroversen bei der Standardisierung der Empfindlichkeitstestung von Hefen gegen Azol-Antimykotika. Mycoses 39 (Suppl. 2), 22-26.
30. 30 To, W.-K., Fothergill, A. W. & Rinaldi, M. G. (1995) Comparative evaluation of macrodilution and Alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 33, 2660-2664.
31. 31 Arias, A., Arevalo, M. P., Andreu, A., Rodriguez, C. & Sierra, A. (1994) In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents. Mycoses 37, 285-289.
32. 32 Simonetti, N., Simonetti, G., Strippoli, V., Callari, A. & Tecca, M. (1997) Susceptibility assays of Candida tropicalis to miconazole. J. Microbiol. Meth. 30, 221-229.
33. 33 Espinel-Ingroff, A., Barchiesi, F., Hazen, K. C., Martinez-Suarez, V. & Scalise, G. (1998) Standardization of antifungal susceptibility testing and clinical relevance. Med. Mycol. 36 (Suppl. 1), 68-78.
34. 34 Pfaller, M. A., Jones, R. N., Messer, S. A. & the SCOPE Participant Group (1998) National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn. Microbiol. Infect. Dis. 30, 121-129.